Guru Ownership Trend
Guru Analysis for ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $102.07 M.
Top institutional holders include Renaissance Technologies and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $2.82 M net inflow during the quarter.
Recent activity highlights Joel Greenblatt who increased their stake by 145.2%. Conversely, Steven Cohen reduced exposure by 53.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ACADIA Pharmaceuticals Inc. (ACAD)
Major holders include Renaissance Technologies ($40.94 M), Steven Cohen ($31.72 M), Ken Fisher ($17.76 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 4.63 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.82 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ACAD. The total reported sell value was $669,512.84.
Yes, 0 managers opened new positions in ACAD, and 3 increased their existing holdings. The total reported buy value was $3.49 M.
